Diagnostic Ultrasound - Abdomen and Pelvis
Acute Pancreatitis TERMINOLOGY Abbreviations • Interstitial edematous pancreatitis (IEP), necrotizing pancreatitis (NP) • Acute pancreatic fluid collection (APFC), ±infection • Acute necrotic collection (ANC), ± infection Definitions • Acute inflammatory process of pancreas with variable involvement of local tissues and remote organ systems IMAGING General Features • Best diagnostic clue ○ Enlarged pancreas with peripancreatic fluid, edema, and obliteration of fat planes • Size ○ Focal or diffuse enlargement Ultrasonographic Findings • Grayscale ultrasound ○ In mild pancreatitis, US signs may be subtle or absent ○ Enlarged, hypoechoic pancreas: Interstitial edema ○ Blurred pancreatic margin: Pancreatic edema and peripancreatic exudate ○ Heterogeneous echotexture: Intrapancreatic necrosis or hemorrhage ○ Pancreatic abscess or infected collections: Difficult to confirm with US; thick walled, mostly anechoic with internal echoes and debris ○ Gallstones or biliary intraductal calculi • Color Doppler ○ Helpful to detect pseudoaneurysm formation and portosplenic venous thrombosis CT Findings • Focal or diffuse enlargement of pancreas with ill-defined margins, infiltration of peripancreatic fat • Homogeneous or mildly heterogeneous enhancement (IEP); focal or diffuse nonenhancement (necrosis) • Complications ○ Peripancreatic collections (APFC and ANC) do not have defined wall < 4 weeks after onset ○ Late collections have defined wall with enhancement: Pseudocyst following APFC; WON (walled-off necrosis) following ANC ○ Pseudoaneurysm: Cystic vascular lesion, enhances like adjacent blood vessels ○ Portal/splenic venous thrombosis: Nonenhancement of thrombosed vein ○ Infection: Presence of gas, unless secondary to fistula to colon or interventional procedure MR Findings • T2WI FS ○ Collections, necrotic areas: Hyperintense ○ Peripancreatic edema, infiltrating fluid: Hyperintense • T1WI C+ ○ Enhancement: Homogeneous or mildly heterogeneous (IEP) vs. focal or diffuse nonenhancement (necrosis) ○ Vascular occlusions: Filling defects or nonenhancement of vessel • MRCP ○ Dilated or normal main pancreatic duct (MPD) ○ Gallstones, choledocholithiasis: Filling defects in gallbladder or common bile duct Imaging Recommendations • Best imaging tool ○ CECT • Protocol advice ○ US best to evaluate for cholelithiasis in acute pancreatitis of unknown etiology ○ CECT best in late phase to delineate extent of inflammation, detect necrosis and complications ○ MR best to detect choledocholithiasis (MRCP) or in patients unable to undergo CECT DIFFERENTIAL DIAGNOSIS Infiltrating Pancreatic Carcinoma • Irregular, heterogeneous, hypoechoic mass • Abrupt obstruction & dilatation of pancreatic duct • Regional nodal metastases: Splenic hilum & porta hepatis • Contiguous organ invasion: Duodenum, stomach, liver, mesentery Lymphoma & Metastases • Nodular, bulky, enlarged pancreas due to infiltration • Retroperitoneal adenopathy • Peripancreatic infiltration (obliteration of fat planes) Autoimmune Pancreatitis • Focal or diffuse enlargement • Narrowed pancreatic duct • Lack of calcifications or fluid collections Perforated Duodenal Ulcer • Penetrating ulcers may infiltrate anterior pararenal space, simulating pancreatitis • < 50% of cases have evidence of extraluminal gas or contrast medium collections • Pancreatic head may be involved "Shock" Pancreas • Infiltration of peripancreatic & mesenteric fat planes following hypotensive episode (e.g., blunt trauma) • Pancreas itself looks normal or diffusely enlarged PATHOLOGY General Features • Etiology ○ Alcohol/gallstones/metabolic/infection/trauma/drugs/E RCP ○ Pathogenesis: Due to reflux of pancreatic enzymes, bile, duodenal contents, and increased ductal pressure – MPD or terminal duct blockage – Edema, spasm; incompetence of sphincter of Oddi • Genetics ○ Hereditary pancreatitis: Autosomal dominant, incomplete penetrance • Associated abnormalities Diagnoses: Pancreas 355
Acute Pancreatitis Diagnoses: Pancreas CT Severity Index Grade CT Findings A Normal pancreas B Focal or diffuse enlargement of gland, contour irregularities & heterogeneous attenuation; no peripancreatic inflammation C Intrinsic pancreatic abnormalities & associated inflammation in peripancreatic fat D Small and usually single, small ill-defined fluid collection E 2 or more large fluid collections, presence of gas in pancreas or retroperitoneum ○ Embryology-anatomy – Annular pancreas: Failure of migration of ventral bud to contact dorsal – Pancreas divisum: Ventral & dorsal pancreatic buds fail to fuse; relative obstruction at minor papilla Gross Pathologic & Surgical Features • Bulky pancreas, necrosis, fluid collection Microscopic Features • Interstitial edematous pancreatitis ○ Edema, congestion, leukocytic infiltrates • Acute hemorrhagic pancreatitis ○ Tissue destruction, fat necrosis, and hemorrhage CLINICAL ISSUES Presentation • Most common signs/symptoms ○ Acute-onset epigastric pain, often radiating to back ○ Tenderness, fever, nausea, vomiting • Clinical profile ○ Diagnosis based on presence of at least 2 out of 3 of the following – Abdominal pain consistent with pancreatitis – Lipase or amylase level > 3x upper limit of normal – CECT, MR, or US findings consistent with acute pancreatitis ○ Other: Hyperglycemia, increased lactate dehydrogenase (LDH), leukocytosis, hypocalcemia, fall in hematocrit, rise in blood urea nitrogen (BUN) Demographics • Age ○ Usually young and middle-aged groups • Gender ○ Males > females Natural History & Prognosis • Revised Atlanta Classification of Acute Pancreatitis:Early phase < 1 week, late phase > 1 week ○ Early phase: Severity based entirely on clinical parameters (APACHE II, Ranson, Marshall scoring system for organ failure, presence of SIRS) ○ Late phase: Severity based on imaging/morphologic criteria, in addition to clinical parameters • Clinical: Presence of organ failure is main determinant of severity; 3 grades ○ Mild: Absence of local or systemic complications, absence of organ failure; usually resolves in early phase; mortality very rare ○ Moderately severe: Transient organ failure (< 48 hours duration); local or systemic complications; may resolve spontaneously; fluid collections, necrosis may require prolonged intervention ○ Severe: Persistent organ failure (> 48 hours duration) • Imaging: CT severity index (CTSI): Point system based on 1 of 5 grades (A-E) and extent of necrosis • Complications ○ APFCs develop into pseudocysts, ANCs develop into walled-off necrosis (WON); either can become infected ○ GI:Hemorrhage, infarction, obstruction, ileus ○ Biliary: Obstructive jaundice ○ Vascular: Pseudoaneurysm, portosplenic vein thrombosis, hemorrhage ○ Disseminated intravascular coagulation (DIC), shock, renal failure Treatment • IEP: Conservative management; nothing by mouth (NPO); gastric tube decompression; analgesics, antibiotics • IEP with complications: Infected or obstructing fluid collections require drainage (surgical, endoscopic, or percutaneous routes) • NP: Need for intervention based on CT severity index; infected necrosis needs surgery/catheter drainage DIAGNOSTIC CHECKLIST Consider • Rule out other pathologies that can cause "peripancreatic infiltration" Image Interpretation Pearls • Bulky, irregularly enlarged pancreas with obliteration of peripancreatic fat planes, peripancreatic collections, abscess formation SELECTED REFERENCES 1. Banks PA et al: Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 62(1):102-11, 2013 2. Thoeni RF: The revised atlanta classification of acute pancreatitis: its importance for the radiologist and its effect on treatment. Radiology. 262(3):751-64, 2012 3. O'Connor OJ et al: Imaging of acute pancreatitis. AJR Am J Roentgenol. 197(2):W221-5, 2011 4. Balthazar EJ: Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology. 223(3):603-13, 2002 356
- Page 326 and 327: Acute Acalculous Cholecystitis TERM
- Page 328 and 329: Acute Acalculous Cholecystitis (Lef
- Page 330 and 331: Chronic Cholecystitis TERMINOLOGY D
- Page 332 and 333: Xanthogranulomatous Cholecystitis T
- Page 334 and 335: Porcelain Gallbladder TERMINOLOGY A
- Page 336 and 337: Hyperplastic Cholecystosis (Adenomy
- Page 338 and 339: Hyperplastic Cholecystosis (Adenomy
- Page 340 and 341: Gallbladder Carcinoma TERMINOLOGY A
- Page 342 and 343: Gallbladder Carcinoma (Left) Sagitt
- Page 344 and 345: Biliary Ductal Dilatation IMAGING G
- Page 346 and 347: Choledochal Cyst TERMINOLOGY Synony
- Page 348 and 349: Choledochal Cyst (Left) Longitudina
- Page 350 and 351: Choledocholithiasis TERMINOLOGY Abb
- Page 352 and 353: Choledocholithiasis (Left) A single
- Page 354 and 355: Biliary Ductal Gas TERMINOLOGY Syno
- Page 356 and 357: Cholangiocarcinoma TERMINOLOGY Syno
- Page 358 and 359: Cholangiocarcinoma (Left) Ultrasoun
- Page 360 and 361: Ascending Cholangitis TERMINOLOGY S
- Page 362 and 363: Ascending Cholangitis (Left) Longit
- Page 364 and 365: Recurrent Pyogenic Cholangitis TERM
- Page 366 and 367: Recurrent Pyogenic Cholangitis (Lef
- Page 368 and 369: AIDS-Related Cholangiopathy TERMINO
- Page 370 and 371: PART II SECTION 3 Pancreas Introduc
- Page 372 and 373: Approach to Pancreatic Sonography C
- Page 374 and 375: Approach to Pancreatic Sonography (
- Page 378 and 379: Acute Pancreatitis (Left) Transvers
- Page 380 and 381: Pancreatic Pseudocyst TERMINOLOGY D
- Page 382 and 383: Pancreatic Pseudocyst (Left) Transv
- Page 384 and 385: Chronic Pancreatitis TERMINOLOGY Ab
- Page 386 and 387: Chronic Pancreatitis (Left) Transve
- Page 388 and 389: Mucinous Cystic Pancreatic Tumor TE
- Page 390 and 391: Mucinous Cystic Pancreatic Tumor (L
- Page 392 and 393: Serous Cystadenoma of Pancreas TERM
- Page 394 and 395: Serous Cystadenoma of Pancreas (Lef
- Page 396 and 397: Intraductal Papillary Mucinous Neop
- Page 398 and 399: Intraductal Papillary Mucinous Neop
- Page 400 and 401: Intraductal Papillary Mucinous Neop
- Page 402 and 403: Pancreatic Ductal Carcinoma TERMINO
- Page 404 and 405: Pancreatic Ductal Carcinoma (Left)
- Page 406 and 407: Pancreatic Neuroendocrine Tumor TER
- Page 408 and 409: Pancreatic Neuroendocrine Tumor (Le
- Page 410 and 411: Solid Pseudopapillary Neoplasm TERM
- Page 412 and 413: Solid Pseudopapillary Neoplasm (Lef
- Page 414 and 415: PART II SECTION 4 Spleen Introducti
- Page 416 and 417: Approach to Splenic Sonography sple
- Page 418 and 419: Approach to Splenic Sonography (Lef
- Page 420 and 421: Approach to Splenic Sonography (Lef
- Page 422 and 423: Splenomegaly TERMINOLOGY Abbreviati
- Page 424 and 425: Splenomegaly (Left) US in a 92-year
Acute Pancreatitis<br />
Diagnoses: Pancreas<br />
CT Severity Index<br />
Grade CT Findings<br />
A Normal pancreas<br />
B Focal or diffuse enlargement of gl<strong>and</strong>, contour irregularities & heterogeneous attenuation; no peripancreatic inflammation<br />
C Intrinsic pancreatic abnormalities & associated inflammation in peripancreatic fat<br />
D Small <strong>and</strong> usually single, small ill-defined fluid collection<br />
E 2 or more large fluid collections, presence of gas in pancreas or retroperitoneum<br />
○ Embryology-anatomy<br />
– Annular pancreas: Failure of migration of ventral bud<br />
to contact dorsal<br />
– Pancreas divisum: Ventral & dorsal pancreatic buds fail<br />
to fuse; relative obstruction at minor papilla<br />
Gross Pathologic & Surgical Features<br />
• Bulky pancreas, necrosis, fluid collection<br />
Microscopic Features<br />
• Interstitial edematous pancreatitis<br />
○ Edema, congestion, leukocytic infiltrates<br />
• Acute hemorrhagic pancreatitis<br />
○ Tissue destruction, fat necrosis, <strong>and</strong> hemorrhage<br />
CLINICAL ISSUES<br />
Presentation<br />
• Most common signs/symptoms<br />
○ Acute-onset epigastric pain, often radiating to back<br />
○ Tenderness, fever, nausea, vomiting<br />
• Clinical profile<br />
○ Diagnosis based on presence of at least 2 out of 3 of the<br />
following<br />
– Abdominal pain consistent with pancreatitis<br />
– Lipase or amylase level > 3x upper limit of normal<br />
– CECT, MR, or US findings consistent with acute<br />
pancreatitis<br />
○ Other: Hyperglycemia, increased lactate dehydrogenase<br />
(LDH), leukocytosis, hypocalcemia, fall in hematocrit, rise<br />
in blood urea nitrogen (BUN)<br />
Demographics<br />
• Age<br />
○ Usually young <strong>and</strong> middle-aged groups<br />
• Gender<br />
○ Males > females<br />
Natural History & Prognosis<br />
• Revised Atlanta Classification of Acute Pancreatitis:Early<br />
phase < 1 week, late phase > 1 week<br />
○ Early phase: Severity based entirely on clinical<br />
parameters (APACHE II, Ranson, Marshall scoring system<br />
for organ failure, presence of SIRS)<br />
○ Late phase: Severity based on imaging/morphologic<br />
criteria, in addition to clinical parameters<br />
• Clinical: Presence of organ failure is main determinant of<br />
severity; 3 grades<br />
○ Mild: Absence of local or systemic complications,<br />
absence of organ failure; usually resolves in early phase;<br />
mortality very rare<br />
○ Moderately severe: Transient organ failure (< 48 hours<br />
duration); local or systemic complications; may resolve<br />
spontaneously; fluid collections, necrosis may require<br />
prolonged intervention<br />
○ Severe: Persistent organ failure (> 48 hours duration)<br />
• Imaging: CT severity index (CTSI): Point system based on 1<br />
of 5 grades (A-E) <strong>and</strong> extent of necrosis<br />
• Complications<br />
○ APFCs develop into pseudocysts, ANCs develop into<br />
walled-off necrosis (WON); either can become infected<br />
○ GI:Hemorrhage, infarction, obstruction, ileus<br />
○ Biliary: Obstructive jaundice<br />
○ Vascular: Pseudoaneurysm, portosplenic vein<br />
thrombosis, hemorrhage<br />
○ Disseminated intravascular coagulation (DIC), shock,<br />
renal failure<br />
Treatment<br />
• IEP: Conservative management; nothing by mouth (NPO);<br />
gastric tube decompression; analgesics, antibiotics<br />
• IEP with complications: Infected or obstructing fluid<br />
collections require drainage (surgical, endoscopic, or<br />
percutaneous routes)<br />
• NP: Need for intervention based on CT severity index;<br />
infected necrosis needs surgery/catheter drainage<br />
DIAGNOSTIC CHECKLIST<br />
Consider<br />
• Rule out other pathologies that can cause "peripancreatic<br />
infiltration"<br />
Image Interpretation Pearls<br />
• Bulky, irregularly enlarged pancreas with obliteration of<br />
peripancreatic fat planes, peripancreatic collections,<br />
abscess formation<br />
SELECTED REFERENCES<br />
1. Banks PA et al: Classification of acute pancreatitis--2012: revision of the<br />
Atlanta classification <strong>and</strong> definitions by international consensus. Gut.<br />
62(1):102-11, 2013<br />
2. Thoeni RF: The revised atlanta classification of acute pancreatitis: its<br />
importance for the radiologist <strong>and</strong> its effect on treatment. Radiology.<br />
262(3):751-64, 2012<br />
3. O'Connor OJ et al: Imaging of acute pancreatitis. AJR Am J Roentgenol.<br />
197(2):W221-5, 2011<br />
4. Balthazar EJ: Acute pancreatitis: assessment of severity with clinical <strong>and</strong> CT<br />
evaluation. Radiology. 223(3):603-13, 2002<br />
356